Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 528

1.

MULTIPARAMETRIC MRI/ULTRASOUND FUSION BIOPSY IMPROVES BUT DOES NOT REPLACE STANDARD TEMPLATE BIOPSY FOR THE DETECTION OF PROSTATE CANCER.

Hanna N, Wszolek MF, Mojtahed A, Nicaise E, Wu B, Gelpi-Hammerschmidt FJ, Salari K, Dahl DM, Blute ML, Harisinghani M, Feldman AS.

J Urol. 2019 May 30:101097JU0000000000000359. doi: 10.1097/JU.0000000000000359. [Epub ahead of print]

PMID:
31144593
2.

Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database.

Seaton M, Hanna A, Boutros C, Hanna N.

Ther Adv Med Oncol. 2019 May 3;11:1758835919842438. doi: 10.1177/1758835919842438. eCollection 2019.

3.

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA.

Hanna N, Trinh QD, Seisen T, Vetterlein MW, Sammon J, Preston MA, Lipsitz SR, Bellmunt J, Menon M, Choueiri TK, Abdollah F.

Eur Urol Oncol. 2018 May;1(1):83-90. doi: 10.1016/j.euo.2018.03.001. Epub 2018 May 15.

PMID:
31100232
4.

Ductal stenting to improve pulmonary blood flow in pulmonary atresia with intact ventricular septum and critical pulmonary stenosis after balloon valvuloplasty.

Haddad RN, Hanna N, Charbel R, Daou L, Chehab G, Saliba Z.

Cardiol Young. 2019 Apr;29(4):492-498. doi: 10.1017/S1047951119000118. Epub 2019 Apr 29.

PMID:
31030705
5.

MicroRNA-Mediated Control of Inflammation and Tolerance in Pregnancy.

Kamity R, Sharma S, Hanna N.

Front Immunol. 2019 Apr 5;10:718. doi: 10.3389/fimmu.2019.00718. eCollection 2019. Review.

6.

Chlorhexidine baths in preterm infants - are we there yet?

Kamity R, Hanna N.

J Perinatol. 2019 Apr 10. doi: 10.1038/s41372-019-0378-x. [Epub ahead of print] No abstract available.

PMID:
30971766
7.

TAVR in Low-Risk Patients: 1-Year Results From the LRT Trial.

Waksman R, Corso PJ, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Buchbinder M, Asch F, Weissman G, Ben-Dor I, Shults C, Bastian R, Craig PE, Ali S, Garcia-Garcia HM, Kolm P, Zou Q, Satler LF, Rogers T.

JACC Cardiovasc Interv. 2019 May 27;12(10):901-907. doi: 10.1016/j.jcin.2019.03.002. Epub 2019 Mar 12.

PMID:
30860059
8.

Reference Expression Profile of Three FBN1 Transcript Isoforms and Their Association with Clinical Variability in Marfan Syndrome.

Benarroch L, Aubart M, Gross MS, Arnaud P, Hanna N, Jondeau G, Boileau C.

Genes (Basel). 2019 Feb 11;10(2). pii: E128. doi: 10.3390/genes10020128.

9.

Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD).

Arnaud P, Hanna N, Benarroch L, Aubart M, Bal L, Bouvagnet P, Busa T, Dulac Y, Dupuis-Girod S, Edouard T, Faivre L, Gouya L, Lacombe D, Langeois M, Leheup B, Milleron O, Naudion S, Odent S, Tchitchinadze M, Ropers J, Jondeau G, Boileau C.

Genet Med. 2019 Feb 11. doi: 10.1038/s41436-019-0444-y. [Epub ahead of print]

PMID:
30739908
10.

SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium.

Hostetler EM, Regalado ES, Guo DC, Hanna N, Arnaud P, Muiño-Mosquera L, Callewaert BL, Lee K, Leal SM, Wallace SE, Rideout AL, Dyack S, Aatre RD, Boileau C, De Backer J, Jondeau G, Milewicz DM.

J Med Genet. 2019 Apr;56(4):252-260. doi: 10.1136/jmedgenet-2018-105583. Epub 2019 Jan 19.

PMID:
30661052
11.

Distinct Mycobacterium marinum phosphatases determine pathogen vacuole phosphoinositide pattern, phagosome maturation, and escape to the cytosol.

Koliwer-Brandl H, Knobloch P, Barisch C, Welin A, Hanna N, Soldati T, Hilbi H.

Cell Microbiol. 2019 Jun;21(6):e13008. doi: 10.1111/cmi.13008. Epub 2019 Feb 7.

PMID:
30656819
12.

Repeated lipopolysaccharide exposure leads to placental endotoxin tolerance.

Kim ML, Maloney C, Klimova N, Gurzenda E, Lin X, Arita Y, Walker T, Fazzari MJ, Hanna N.

Am J Reprod Immunol. 2019 Feb;81(2):e13080. doi: 10.1111/aji.13080. Epub 2019 Jan 11.

PMID:
30586203
13.

Diagnostic accuracy of a calibrated abdominal compression to predict fluid responsiveness in children.

Jacquet-Lagrèze M, Tiberghien N, Evain JN, Hanna N, Courtil-Teyssedre S, Lilot M, Baudin F, Chardonnal L, Bompard D, Koffel C, Portefaix A, Javouhey E, Fellahi JL.

Br J Anaesth. 2018 Dec;121(6):1323-1331. doi: 10.1016/j.bja.2018.06.030. Epub 2018 Sep 6.

PMID:
30442260
14.

Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.

Nathenson MJ, Barysauskas CM, Nathenson RA, Regine WF, Hanna N, Sausville E.

World J Surg Oncol. 2018 Oct 11;16(1):203. doi: 10.1186/s12957-018-1505-4.

15.

Reply to the letter to the editor 'A centralised multidisciplinary clinic approach for germ cell tumours' by Crawford.

Albany C, Adra N, Snavely A, Cary C, Masterson T, Foster R, Kesler K, Ulbright T, Cheng L, Chovanec M, Taza F, Hanna N, Einhorn L.

Ann Oncol. 2018 Nov 1;29(11):2264-2265. doi: 10.1093/annonc/mdy418. No abstract available.

PMID:
30307469
16.

Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis.

Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Asch F, Weissman G, Ben-Dor I, Shults C, Bastian R, Craig PE, Garcia-Garcia HM, Kolm P, Zou Q, Satler LF, Corso PJ.

J Am Coll Cardiol. 2018 Oct 30;72(18):2095-2105. doi: 10.1016/j.jacc.2018.08.1033. Epub 2018 Aug 28.

PMID:
30170075
17.

Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.

Calaway AC, Foster RS, Adra N, Masterson TA, Albany C, Hanna NH, Einhorn LH, Cary C.

J Clin Oncol. 2018 Oct 10;36(29):2950-2954. doi: 10.1200/JCO.18.00431. Epub 2018 Aug 29.

PMID:
30156983
18.

Contemporary perceptions of human papillomavirus and penile cancer: Perspectives from a national survey.

Zavaski ME, Hanske J, Löppenberg B, Cole AP, Hanna N, Gupta S, Eswara JR, Preston MA, Kibel AS, Lipsitz SR, Sun M, Trinh QD, Meyer CP.

Can Urol Assoc J. 2019 Feb;13(2):32-37. doi: 10.5489/cuaj.5366. Epub 2018 Jul 31.

19.

Marfan Syndrome Variability: Investigation of the Roles of Sarcolipin and Calcium as Potential Transregulator of FBN1 Expression.

Benarroch L, Aubart M, Gross MS, Jacob MP, Arnaud P, Hanna N, Jondeau G, Boileau C.

Genes (Basel). 2018 Aug 21;9(9). pii: E421. doi: 10.3390/genes9090421.

20.

Association of modifiers and other genetic factors explain Marfan syndrome clinical variability.

Aubart M, Gazal S, Arnaud P, Benarroch L, Gross MS, Buratti J, Boland A, Meyer V, Zouali H, Hanna N, Milleron O, Stheneur C, Bourgeron T, Desguerre I, Jacob MP, Gouya L, Génin E, Deleuze JF, Jondeau G, Boileau C.

Eur J Hum Genet. 2018 Dec;26(12):1759-1772. doi: 10.1038/s41431-018-0164-9. Epub 2018 Aug 7.

PMID:
30087447
21.

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Use for Subclassification and Genotyping of Lung Non-Small-Cell Carcinoma.

Raad S, Hanna N, Jalal S, Bendaly E, Zhang C, Nuguru S, Oueini H, Diab K.

South Med J. 2018 Aug;111(8):484-488. doi: 10.14423/SMJ.0000000000000846.

PMID:
30075474
22.

Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection.

Renard M, Francis C, Ghosh R, Scott AF, Witmer PD, Adès LC, Andelfinger GU, Arnaud P, Boileau C, Callewaert BL, Guo D, Hanna N, Lindsay ME, Morisaki H, Morisaki T, Pachter N, Robert L, Van Laer L, Dietz HC, Loeys BL, Milewicz DM, De Backer J.

J Am Coll Cardiol. 2018 Aug 7;72(6):605-615. doi: 10.1016/j.jacc.2018.04.089.

23.

The impact of an adrenal incidentaloma algorithm on the evaluation of adrenal nodules.

Eldeiry LS, Alfisher MM, Callahan CF, Hanna NN, Garber JR.

J Clin Transl Endocrinol. 2018 Jul 5;13:39-45. doi: 10.1016/j.jcte.2018.07.001. eCollection 2018 Sep.

24.

MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants.

Wallace SE, Regalado ES, Gong L, Janda AL, Guo DC, Russo CF, Kulmacz RJ, Hanna N, Jondeau G, Boileau C, Arnaud P, Lee K, Leal SM, Hannuksela M, Carlberg B, Johnston T, Antolik C, Hostetler EM, Colombo R, Milewicz DM.

Genet Med. 2019 Jan;21(1):144-151. doi: 10.1038/s41436-018-0038-0. Epub 2018 Jun 20.

25.

Seasonal Variations in Water-Quality, Antibiotic Residues, Resistant Bacteria and Antibiotic Resistance Genes of Escherichia coli Isolates from Water and Sediments of the Kshipra River in Central India.

Diwan V, Hanna N, Purohit M, Chandran S, Riggi E, Parashar V, Tamhankar AJ, Stålsby Lundborg C.

Int J Environ Res Public Health. 2018 Jun 17;15(6). pii: E1281. doi: 10.3390/ijerph15061281.

26.

How the acoustic resonances of the subglottal tract affect the impedance spectrum measured through the lips.

Hanna N, Smith J, Wolfe J.

J Acoust Soc Am. 2018 May;143(5):2639. doi: 10.1121/1.5033330.

PMID:
29857706
27.

Catheter closure of a recanalized vertical vein after repair of total anomalous pulmonary venous connection.

Charbel R, Hanna N, Daou L, Saliba Z.

Clin Case Rep. 2018 Mar 11;6(5):843-846. doi: 10.1002/ccr3.1443. eCollection 2018 May.

28.

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes.

Belkacemi Y, Hanna NE, Besnard C, Majdoul S, Gligorov J.

Front Oncol. 2018 Apr 17;8:112. doi: 10.3389/fonc.2018.00112. eCollection 2018. Review.

29.

Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers.

Carter-Harris L, Slaven JE Jr, Monahan PO, Shedd-Steele R, Hanna N, Rawl SM.

Prev Med Rep. 2018 Feb 3;10:49-54. doi: 10.1016/j.pmedr.2018.01.018. eCollection 2018 Jun.

30.

Presence of antibiotic residues in various environmental compartments of Shandong province in eastern China: Its potential for resistance development and ecological and human risk.

Hanna N, Sun P, Sun Q, Li X, Yang X, Ji X, Zou H, Ottoson J, Nilsson LE, Berglund B, Dyar OJ, Tamhankar AJ, Stålsby Lundborg C.

Environ Int. 2018 May;114:131-142. doi: 10.1016/j.envint.2018.02.003. Epub 2018 Mar 2.

31.

Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets.

Trofimov V, Kicka S, Mucaria S, Hanna N, Ramon-Olayo F, Del Peral LV, Lelièvre J, Ballell L, Scapozza L, Besra GS, Cox JAG, Soldati T.

Sci Rep. 2018 Mar 2;8(1):3939. doi: 10.1038/s41598-018-22228-6.

32.

Validation of a smartphone-based event recorder for arrhythmia detection.

Narasimha D, Hanna N, Beck H, Chaskes M, Glover R, Gatewood R, Bourji M, Gudleski GD, Danzer S, Curtis AB.

Pacing Clin Electrophysiol. 2018 May;41(5):487-494. doi: 10.1111/pace.13317. Epub 2018 Apr 15.

PMID:
29493801
33.

Short-Term Effects of Cold Liquids on the Pharyngeal Swallow in Preterm Infants with Dysphagia: A Pilot Study.

Ferrara L, Kamity R, Islam S, Sher I, Barlev D, Wennerholm L, Redstone F, Hanna N.

Dysphagia. 2018 Oct;33(5):593-601. doi: 10.1007/s00455-018-9877-8. Epub 2018 Feb 12.

PMID:
29435661
34.

Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis.

Sun M, Cole AP, Hanna N, Mucci LA, Berry DL, Basaria S, Ahern DK, Kibel AS, Choueiri TK, Trinh QD.

J Urol. 2018 Jun;199(6):1417-1425. doi: 10.1016/j.juro.2017.11.136. Epub 2018 Feb 2.

PMID:
29410294
35.

Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.

Gridelli C, Baas P, Barlesi F, Ciardiello F, Crinò L, Felip E, Gadgeel S, Papadimitrakopoulou V, Paz-Ares L, Planchard D, Perol M, Hanna N, Sgambato A, Casaluce F, de Marinis F.

Clin Lung Cancer. 2018 Jul;19(4):301-314. doi: 10.1016/j.cllc.2017.12.010. Epub 2017 Dec 22. Review.

PMID:
29396237
36.

Coping Skills Practice and Symptom Change: A Secondary Analysis of a Pilot Telephone Symptom Management Intervention for Lung Cancer Patients and Their Family Caregivers.

Winger JG, Rand KL, Hanna N, Jalal SI, Einhorn LH, Birdas TJ, Ceppa DP, Kesler KA, Champion VL, Mosher CE.

J Pain Symptom Manage. 2018 May;55(5):1341-1349.e4. doi: 10.1016/j.jpainsymman.2018.01.005. Epub 2018 Jan 31.

37.

Comparative effectiveness of robot-assisted vs. open radical cystectomy.

Hanna N, Leow JJ, Sun M, Friedlander DF, Seisen T, Abdollah F, Lipsitz SR, Menon M, Kibel AS, Bellmunt J, Choueiri TK, Trinh QD.

Urol Oncol. 2018 Mar;36(3):88.e1-88.e9. doi: 10.1016/j.urolonc.2017.09.018. Epub 2017 Dec 23.

PMID:
29277584
38.

Can radiotherapy potentiate the effectiveness of immune checkpoint inhibitors in lung cancer?

Cheng M, Durm G, Hanna N, Einhorn LH, Kong FS.

Future Oncol. 2017 Dec;13(28):2503-2505. doi: 10.2217/fon-2017-0405. Epub 2017 Nov 23. No abstract available.

39.

Reply to M.E.H.M. Van Hoef.

Hanna N, Temin S, Oliver TK, Masters G.

J Clin Oncol. 2018 Feb 1;36(4):427-428. doi: 10.1200/JCO.2017.76.3599. Epub 2017 Nov 22. No abstract available.

PMID:
29166169
40.

Development and Usability Testing of a Computer-Tailored Decision Support Tool for Lung Cancer Screening: Study Protocol.

Carter-Harris L, Comer RS, Goyal A, Vode EC, Hanna N, Ceppa D, Rawl SM.

JMIR Res Protoc. 2017 Nov 16;6(11):e225. doi: 10.2196/resprot.8694.

41.

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors.

Albany C, Adra N, Snavely AC, Cary C, Masterson TA, Foster RS, Kesler K, Ulbright TM, Cheng L, Chovanec M, Taza F, Ku K, Brames MJ, Hanna NH, Einhorn LH.

Ann Oncol. 2018 Feb 1;29(2):341-346. doi: 10.1093/annonc/mdx731.

42.

Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.

Cary C, Jacob JM, Albany C, Masterson TA, Hanna NH, Einhorn LH, Foster RS.

Clin Genitourin Cancer. 2018 Apr;16(2):e307-e313. doi: 10.1016/j.clgc.2017.10.008. Epub 2017 Oct 16.

PMID:
29104087
43.

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.

Adra N, Einhorn LH, Althouse SK, Ammakkanavar NR, Musapatika D, Albany C, Vaughn D, Hanna NH.

Ann Oncol. 2018 Jan 1;29(1):209-214. doi: 10.1093/annonc/mdx680.

PMID:
29045540
44.

Long-term toxicity of cisplatin in germ-cell tumor survivors.

Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C.

Ann Oncol. 2017 Nov 1;28(11):2670-2679. doi: 10.1093/annonc/mdx360. Review.

45.

Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients.

Smith TJ, Hanna N, Johnson D, Baker S Jr, Biermann WA, Brahmer J, Ellis PM, Giaccone G, Hesketh PJ, Jaiyesimi I, Leighl NB, Riely GJ, Schiller JH, Schneider BJ, Tashbar J, Temin S, Masters G.

J Oncol Pract. 2017 Dec;13(12):780-783. doi: 10.1200/JOP.2017.027367. Epub 2017 Oct 5. No abstract available.

PMID:
28981389
46.

Pentoxifylline inhibits lipopolysaccharide-induced inflammatory mediators in human second trimester placenta explants.

Speer EM, Lin X, Murthy A, Hou W, Islam S, Hanna N.

Placenta. 2017 Oct;58:60-66. doi: 10.1016/j.placenta.2017.08.006. Epub 2017 Aug 12.

PMID:
28962697
47.

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

Tandstad T, Kollmannsberger CK, Roth BJ, Jeldres C, Gillessen S, Fizazi K, Daneshmand S, Lowrance WT, Hanna NH, Albany C, Foster R, Cedermark GC, Feldman DR, Powles T, Lewis MA, Grimison PS, Bank D, Porter C, Albers P, De Santis M, Srinivas S, Bosl GJ, Nichols CR.

J Clin Oncol. 2017 Nov 1;35(31):3525-3528. doi: 10.1200/JCO.2017.73.4723. Epub 2017 Aug 30. No abstract available.

48.

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Hanna N, Johnson D, Temin S, Masters G.

J Oncol Pract. 2017 Dec;13(12):832-837. doi: 10.1200/JOP.2017.026716. Epub 2017 Aug 29. No abstract available.

PMID:
28850309
49.

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Hanna N, Johnson D, Temin S, Baker S Jr, Brahmer J, Ellis PM, Giaccone G, Hesketh PJ, Jaiyesimi I, Leighl NB, Riely GJ, Schiller JH, Schneider BJ, Smith TJ, Tashbar J, Biermann WA, Masters G.

J Clin Oncol. 2017 Oct 20;35(30):3484-3515. doi: 10.1200/JCO.2017.74.6065. Epub 2017 Aug 14.

PMID:
28806116
50.

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer.

Gaschler-Markefski B, Sikken P, Heymach JV, Gottfried M, Mellemgaard A, Novello S, Gann CN, Barrueco J, Reck M, Hanna NH, Kaiser R.

ESMO Open. 2017 Apr 11;2(1):e000102. doi: 10.1136/esmoopen-2016-000102. eCollection 2017.

Supplemental Content

Support Center